We've upgraded AI Search on TaxTMI with two powerful modes:
1. Basic • Quick overview summary answering your query with references• Category-wise results to explore all relevant documents on TaxTMI
2. Advanced • Includes everything in Basic • Detailed report covering: - Overview Summary - Governing Provisions [Acts, Notifications, Circulars] - Relevant Case Laws - Tariff / Classification / HSN - Expert views from TaxTMI - Practical Guidance with immediate steps and dispute strategy
• Also highlights how each document is relevant to your query, helping you quickly understand key insights without reading the full text.Help Us Improve - by giving the rating with each AI Result:
Appellate Tribunal rules on physician samples valuation under Central Excise Act The Appellate Tribunal CESTAT NEW DELHI dismissed the Revenue's appeal concerning the valuation of physician samples under the Central Excise Valuation ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Appellate Tribunal rules on physician samples valuation under Central Excise Act
The Appellate Tribunal CESTAT NEW DELHI dismissed the Revenue's appeal concerning the valuation of physician samples under the Central Excise Valuation Rules. The Tribunal upheld the decision that the transaction value should be followed as per Section 4(1)(a) of the Central Excise Act, 1944, and that Section 4A does not apply in such cases. Relying on previous cases and consistent application of the principle, the Tribunal found no merit in the Revenue's arguments, leading to the dismissal of the appeal.
Issues: Valuation of physician samples under Central Excise Valuation Rules
In this judgment by the Appellate Tribunal CESTAT NEW DELHI, the issue involved is the valuation of physician samples cleared by the respondents, who are engaged in the manufacture of pharmaceutical preparations. The dispute arose when the Original Authority valued the physician samples under Rule 4 of the Central Excise Valuation (Determination of Price of Excisable Goods) Rules, 2000, resulting in a confirmation of differential duty and penalty. On appeal, the Commissioner (Appeals) set aside the original order, leading to the Revenue filing an appeal.
Analysis:
The Tribunal, in its decision, referred to a previous case involving the respondents where it was held that when there is a transaction value available on the sale of the goods in question, such transaction value should be followed in accordance with Section 4 (1)(a) of the Central Excise Act, 1944. The Tribunal emphasized that the provisions of Section 4A are not applicable in such scenarios. This decision was supported by citing various other cases where a similar approach had been taken, including Themis Laboratories Pvt. Ltd., Omni Protech Drugs Pvt. Ltd., Allianz Bio Science Pvt. Ltd., Piramal Enterprises Ltd., and CCE Vs. Sidmak Laboratories(India) Ltd.
Based on the precedent set in the respondent's earlier case and the consistent application of the principle regarding transaction value, the Tribunal found no merit in the Revenue's appeal. Consequently, the appeal by the Revenue was dismissed by the Tribunal. The judgment was delivered after hearing both sides and perusing the appeal records, with the order being dictated and pronounced in open court.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.